A randomized, double-blind, placebo parallel controlled clinical trial of Shuanghua Baihe Tablets in the treatment of recurrent aphthous ulcer

Peking University School and Hospital of Stomatology0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Meet the diagnostic criteria for recurrent aphthous ulcer;
•(2) The clinical classification is mild recurrent oral ulcer;
•(3) The course of the disease should not exceed 48 hours, and no treatment has been performed;
•(4) Aged 18-65 years, male or female.

•(1) Patients with other obvious painful lesions that may affect the observation of curative effect, such as: patients with pericoronitis, acute pulpitis, acute apical inflammation and other diseases;
•(2) Having used analgesics, antibiotics, anti-inflammatory drugs 48 hours before the study, and having used corticosteroids, immunomodulators and other western medicines with the same or similar effects within three months;
•(3) Those who are accompanied by other diseases, such as the circulatory system, endocrine system, digestive system, malignant tumors, and autoimmune diseases;
•(4) Patients with severe cardiovascular, cerebrovascular, severe cardiopulmonary insufficiency, liver, kidney, hematopoietic system and other serious primary diseases, diseases, mental disorders, and intellectual disabilities;
•(5) People with allergies and a history of allergies to drugs and food;
•(6) Pregnant and intentional pregnancy women or lactating women;
•(7) Those who have participated in clinical trials within the past three months;
•(8) The investigator believes that it is not suitable to participate in clinical trials.

发起方

Peking University School and Hospital of Stomatology